Shi‐Ming Tu

Also affiliated with University of Arkansas for Medical Sciences

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Phase 2 study of pembrolizumab in patients with advanced rare cancers”.

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000347

N/A

4.0DataRank · unranked

131 citations

Funda Meric‐Bernstam, Bettzy Stephen, Daniel D. Karp, Joud Hajjar, Jordi Rodon Ahnert +35 more

Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors

The Oncologist(2021)10.1002/onco.13682

N/A

1.4DataRank · unranked

47 citations

Henry Hiep Vo, Vivek Subbiah, Filip Jankú, Sarina A. Piha‐Paul, Bülent Yılmaz +7 more

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad155

N/A

0.609DataRank · unranked

57 citations

Amin H. Nassar, Gregory R. Pond, Tony Zhuang, Viraj A. Master, Bassel Nazha +50 more

Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study

npj Precision Oncology(2021)10.1038/s41698-021-00159-2

N/A

0.505DataRank · unranked

28 citations

David S. Hong, Siqing Fu, Daniel D. Karp, Sarina A. Piha‐Paul, Merrill S. Kies +16 more

A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.027

N/A

0.435DataRank · unranked

7 citations

Nicholas Spetsieris, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio +14 more

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.05.013

N/A

0.425DataRank · unranked

16 citations

Myrto Boukovala, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio +15 more

Start Time End Time Integration (STETI): Analyzing Trends in Kidney Cancer Survival Time Data

Preprints.org(2025)10.20944/preprints202504.1239.v1

N/A

0DataRank · unranked

0 citations

Daniel Berleant, Michael Bauer, Peng-Hung Tsai, Shi‐Ming Tu, Thobani Chaduka

Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classifications

Cancer(2020)10.1002/cncr.33051

N/A

0DataRank · unranked

14 citations

Andrew G. McIntosh, Chalairat Suk‐Ouichai, Luis Segarra, Levi C. Holland, Bryan Fellman +9 more

Stem Cell Theory of Cancer: Rude Awakening or Bad Dream from Cancer Dormancy?

Cancers(2022)10.3390/cancers14030655

N/A

0DataRank · unranked

9 citations

Marcos R. Estecio, Sue-Hwa Lin, Niki M. Zacharias, Shi‐Ming Tu

Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases

Human Pathology(2024)10.1016/j.humpath.2024.105673

N/A

0DataRank · unranked

0 citations

Lan Zheng, Hossein Hosseini, John F. Ward, Louis L. Pisters, Matthew T. Campbell +4 more

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1917

N/A

0DataRank · unranked

2 citations

John F. Ward, Wayne L. Hofstetter, David C. Rice, José A. Karam, Louis L. Pisters +24 more

Start Time End Time Integration (STETI): Method for Including Recent Data to Analyze Trends in Kidney Cancer Survival

Healthcare(2025)10.3390/healthcare13121451

N/A

0DataRank · unranked

1 citations

Daniel Berleant, Michael Bauer, Peng-Hung Tsai, Shi‐Ming Tu, Thobani Chaduka